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Abstract  
The Promoting Early Presentation intervention (PEP) increased older women’s breast cancer 
awareness after 2 years in a randomised controlled trial. We measured whether this 
increase was sustained at 3 years and the effect on breast screening self-referral. We 
randomly allocated 867 women attending their final invited breast screening appointment 
to the PEP Intervention or usual care. We examined breast cancer awareness after 3 years 
and breast screening self-referrals after 4 years. Women in the PEP intervention arm had 
higher breast cancer awareness at 3 years than the usual care arm (odds ratio 10.4, 95% 
confidence interval 3.1 to 34.8). There were no difference in proportions self-referring for 
breast screening between arms, but statistical power was limited. The PEP Intervention has 
a sustained effect on breast cancer awareness in older women. The effect on self-referral 
for breast screening is unclear. 
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Introduction  
Women who delay presentation of breast cancer symptoms have poorer outcomes and 
evidence suggests this is because they present with more advanced disease 1, 2. This is a 
particular problem in older women, who are more likely to have poor breast cancer 
awareness, to delay presentation with breast cancer symptoms, and have worse survival 
from the disease 3, 4. 
In the UK, women are invited for breast screening every three years from the age of 50 to 70 
with some women being invited from 47 to 73 as part of a trial 5. Following women’s final 
invited appointment for breast screening, women may contact the screening service every 
three years to request further screening.  This is known as self-referral, however, the 
proportion of women aged 70 and over who self-referring for breast screening is relatively 
low at about 20%6.This report summarises further results of the randomised controlled trial: 
the effect of the PEP Intervention on breast cancer awareness after three years, and self-
referral for breast screening in the four years after randomisation. 
Methods 
We developed the Promoting Early Presentation (PEP) Intervention to provide older women 
with the knowledge, motivation, confidence and skills to present promptly with breast 
cancer symptoms 7, 8. Delivered by a health professional in a few minutes, it is supported by 
a booklet.  
The PEP Intervention was delivered women attending their final invited breast screening 
appointment. The intervention was a scripted ten-minute one-to-one interaction which was 
supported by a booklet. The details of the trial’s methods have already been published; in 
brief, eight hundred and sixty seven women aged 67-70 attending their final routine 
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appointment for breast screening in the NHS Breast Screening Programme were randomly 
allocated to receive the PEP Intervention or usual care9.  
The main outcome was breast cancer awareness, a validated composite score encompassing 
knowledge of breast cancer symptoms, age-related risk of breast cancer and frequency of 
breast checking 10. Participants were considered breast cancer aware if they recognised 5 or 
more non-lump symptoms, identified a 70 year old as most at risk of developing breast 
cancer (compared with a 30 year old, a 50 year old or a woman of any age) and reported 
checking their breasts at least once a month. These items were combined to form an ordinal 
composite score of breast awareness. Each component was given equal weighting and 
contributed one point to the total score ranging from 0 to 3 with a score of 3 being breast 
cancer aware.  
The PEP Intervention increased breast cancer awareness compared to usual care at two 
years follow up (Forbes 2012). This report focuses on reporting the re-assessment of breast 
cancer awareness at three years follow-up and the rates of self-referral for breast screening 
after four years. 
Breast cancer awareness was assessed by postal questionnaire 3 years after receiving the 
intervention. Four years after every participant had attended their final routine breast 
screening appointment we asked NHS Breast Screening Services to tell us which women in 
the trial had self-referred for further breast screening. 
Analysis 
We used generalized estimating equations to analyse the change in proportion that was 
breast cancer aware from baseline to three years, comparing PEP Intervention versus usual 
care arm. The analyses were carried out by intention-to-treat. In subsequent analyses, we 
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adjusted the estimates controlling for health professional, centre, and demographic 
characteristics at baseline.  
We examined whether, four years after recruitment, there were differences in the 
proportions that had self-referred for breast screening between the PEP intervention and 
usual care using logistic regression.  
All analyses were performed using Stata version 11.2 (College Station, TX). 
Results 
The data, and consort diagram for this trial have been shown in a previous report 11. At 
three years, 457/565 (81%) of randomised women completed the breast cancer awareness 
questionnaire: 222/279 (78%) in the PEP Intervention arm and 235/286 (82%) in the usual 
care arm. Women who completed the questionnaire at three years were more likely to be of 
White ethnic group and to live in less socioeconomically deprived areas than those who did 
not, but there were no differences in educational status or baseline breast cancer 
awareness. Non-response by these characteristics was very similar in both arms.  
Breast cancer awareness 
Women in the PEP Intervention arm were more likely to be breast cancer aware compared 
with the usual care arm at three years (17% versus 4%, odds ratio (OR): 10.4, 95% 
confidence interval (CI) 3.1 to 34.8; p<0.001) (Table 1). The most striking effect of the PEP 
Intervention was on knowledge of the age at which women were most at risk of breast 
cancer. In the PEP Intervention, the proportion who knew that a 70 year old was at higher 
risk than a younger woman or a woman of any age was about 22%, compared with 8% in the 
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usual care arm (OR: 3.7; CI: 1.9-7.4; p<0.001). Including centre, health professional, and 
baseline demographic s in the model made very little difference to the results.  
In the usual care arm 64.9% identified 5-9 non-lump symptoms compared to 73.2% in PEP 
intervention group (OR: 1.2; CI: 0.8-1.8; p=0.3) and 66.2% in usual care who check breasts at 
least once month to 78.2% in PEP intervention group (OR: 1.7; CI: 1.1-2.5; p<0.01). 
Self-referral for breast cancer screening 
Three-hundred and forty-one women were included in the analysis of breast screening 
attendance. We excluded 232 women from this analysis because they had died or 
withdrawn consent (n=33), they were known to be taking part in other studies of breast 
screening or promoting early presentation of breast cancer (n= 157), or they were invited 
for an additional round of screening by the breast screening service (n=42). 
There were no significant differences in the proportions who had self-referred for breast 
screening between PEP Intervention and usual care arms (35/168 versus 31/173; 21% versus 
18%; OR 0.8; CI 0.5 to 1.4). 
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Table 1. Breast cancer Awareness at baseline and three years post-randomisation 
 Baseline Three years 
 Usual care PEP Intervention Usual care PEP Intervention 
Breast cancer awareness 
Number (%) breast cancer aware* 9/267 5/272 9/225 36/210 
(3.4) (1.8) (4.0) (17.1) 
Odds ratio† (95% CI), p value   
(versus usual care) 
  1.0 10.4 (3.1 to 34.8) 
p<0.001 
Knowledge of breast cancer symptoms  
Identified five or more non-lump symptoms 111/284 122/280 148/228 158/216 
(39.1) (43.6) (64.9) (73.2) 
Odds ratio† (95% CI), p value (versus usual 
care) 
  1.0 1.2 (0.8 to 1.8) 
p=0.3 
Knowledge that risk increases with age 
Identified a 70 year old as at highest risk of 
breast cancer 
30/269 28/276 18/233 47/215 
(11.2) (10.1) (7.7) (21.9) 
Odds ratio† (95% CI), p value (versus usual 
care) 
  1.0 3.7 (1.9 to 7.4) 
p=<0.001 
Breast checking 
Reported breast checking at least once a 
month 
152/285 154/284 155/234 172/220 
(53.3) (54.2) (66.2) (78.2) 
Odds ratio† (95% CI), p value (versus usual 
care) 
  1.0 1.7 (1.1 to 2.5) 
p<0.01 
 
* A woman was considered breast cancer aware if she: identified at least five non-lump symptoms AND identified that a 70 year old woman is most at risk of breast cancer (rather than a 30 year old, a 50 year old or a 
woman of any age)  AND reported checking her breasts at least once a month.
 
† 
Crude odds ratios – not adjusted for baseline characteristics   
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Conclusion  
The PEP Intervention increased breast cancer awareness in older women and the effect was 
sustained at three years but diminished over the three years. The effect was most striking 
for knowledge that the risk of breast cancer increases with age. We found no effect of the 
PEP intervention on self-referral for breast screening. 
A strength of the analysis of breast cancer awareness is the very high response rate. 
Moreover, we found no evidence that response bias i.e. differences in pattern of response 
by arm - could explain the results.  
In both arms, knowledge that the risk of breast cancer increases with age was low compared 
to knowledge of breast cancer symptoms and frequency of breast checking, limiting the 
overall proportion of participants being able to achieve a score of 3 for breast cancer 
awareness. Future work should investigate why knowledge that risk of breast cancer 
increases with age is difficult for participants to retain and to develop better methods of 
communicating this message. 
The analysis of self-referrals was limited by low numbers: we would have needed a sample 
of about 7000 women to find the observed difference in proportions self-referring between 
PEP intervention and usual care arms statistically significant, with 80% power and 
significance level of 5%.  It is also possible that we collected data too soon after 
randomisation (four years) and that some women may have self-referred for breast 
screening later.  
The PEP intervention has recently been tested in routine clinical practice and has been 
found to be effective at increasing breast cancer awareness with sustained effects at one 
year  (Lindsay Forbes/Rachael Dodd, personal communication)12. In 2013, the All Party 
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Parliamentary Group on Breast Cancer (2013) recommended that the PEP Intervention 
should be rolled out in more breast screening services, in order to evaluate the effect on 
stage at diagnosis and survival, and be tested in a variety of community-based health care 
settings 13. If the PEP Intervention is implemented across the whole NHS Breast Screening 
Programme, it has potential to prevent avoidable deaths from breast cancer, resulting from 
delayed presentation of cancer symptoms in older women. 
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